Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea

NCT01181570 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis
Sleep Apnea, Obstructive

Interventions

DRUG: Adalimumab
DRUG: Placebo

Sponsor

Innovaderm Research Inc.

Collaborators

[object Object]